Cyclophosphamide (tablet)

DRUG2 trials

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Breast CancerTriple Negative Breast Cancer

Phase 2

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

SuspendedNCT02897050

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityBreast Cancer

Start: 2016-09-30End: 2024-09-30Target: 170Updated: 2022-04-20

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

Not yet recruitingNCT06229067

Cancer Institute and Hospital, Chinese Academy of Medical SciencesBreast Cancer, Triple Negative Breast Cancer

Start: 2024-01-19End: 2027-01-19Target: 182Updated: 2024-01-29